Ipilimumab vs Methylene Blue
Ipilimumab vs Methylene Blue: Overview
This comparison examines the pharmacological differences between Ipilimumab and Methylene Blue.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days.
Chemical Properties
Type: Ipilimumab β Antibody; Methylene Blue β Small molecule.